Condition: Bronchiectasis · Sponsor: GlaxoSmithKline
This study is designed to find out how effective and safe a new drug, GSK3862995B, is for adult participants with bronchiectasis, a chronic lung disease. The study will also test how the body processes the drug and to check for any immune reactions. Participants will be divided into groups randomly to receive either one of two different doses of the study drug or a placebo. The main goal of the study is to see how well the drug works compared to the placebo in helping those with bronchiectasis.
This description comes directly from the study's public registry record.
US GSK Clinical Trials Call Center · 877-379-3718 · GSKClinicalSupportHD@gsk.com
EU GSK Clinical Trials Call Center · +44 (0) 20 89904466 · GSKClinicalSupportHD@gsk.com
Always discuss trial participation with your own doctor first.
| GSK Investigational Site | Mobile, Alabama, United States | Recruiting |
| GSK Investigational Site | La Palma, California, United States | Recruiting |
| GSK Investigational Site | Miami, Florida, United States | Recruiting |
| GSK Investigational Site | Miami, Florida, United States | Recruiting |
| GSK Investigational Site | Naples, Florida, United States | Recruiting |
| GSK Investigational Site | Plantation, Florida, United States | Recruiting |
| GSK Investigational Site | St. Petersburg, Florida, United States | Recruiting |
| GSK Investigational Site | Rockville, Maryland, United States | Recruiting |
| GSK Investigational Site | DuBois, Pennsylvania, United States | Recruiting |
| GSK Investigational Site | Anderson, South Carolina, United States | Recruiting |
| GSK Investigational Site | Rock Hill, South Carolina, United States | Recruiting |
| GSK Investigational Site | Spartanburg, South Carolina, United States | Recruiting |
+ 34 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07201051